Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
ETF Daily Report: A-shares today show a restorative rebound driven by a rally in the external markets.
Today’s A-share market is choppy but rebounds. The Shanghai Composite Index rose 1.78%, the Shenzhen Component Index rose 1.43%, and the ChiNext Index rose 0.50%. Total trading volume across the Shanghai and Shenzhen markets was approximately CNY 2.10 trillion, down compared with the previous trading day. Individual stocks saw more gainers than decliners, with more than 5,100 stocks rising across the entire market. At the sector level, precious metals, power, and pharmaceuticals led the gains; oil and natural gas, coal, and other sectors posted notable declines.
(Source: Caixin Global)
(Source: Wind)
Late on March 23, overseas markets got pulled into fluctuations over whether “the U.S. and Iran actually had talks,” with both sides sticking to their own accounts, but overall they maintained an upward trend.
As for whether they actually talked or not, it’s impossible to know, but today’s A-shares also showed a restorative rebound, driven by improving conditions in the broader market.
Looking ahead, geopolitical risk remains ongoing, and the risk of a blockade of the Strait of Hormuz still exists. Although there may be short-term technical repairs, investors remain cautious about the rebound’s strength and duration. If geopolitical tensions ease or if there are relatively newer and sustainable industrial catalysts, the market may be able to restart an offensive posture. Before that, investors are advised to maintain a prudent strategy.
In terms of positioning, with market risk appetite falling and a heightened risk-hedging sentiment, in the short term it may be appropriate to give some attention to related areas that benefit from the oil-price benchmark moving higher. Investors may also consider broad-based products that package industry leaders in one go, such as the CSI A500 ETF (159338).
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Today, the power sector performed relatively well. Guotai Power Green Energy ETF (159669) surged 3.99%.
First, total electricity consumption across the whole society in January–February 2026 increased year over year by +6.1%, compared with the year-over-year growth rate of electricity consumption in December 2025 of +3.3pct. By sector, in January–February 2026, electricity consumption for primary industry/secondary industry/tertiary industry/residents grew year over year by +7.4%/+6.3%/+8.3%/+2.7%, respectively, compared with the year-over-year growth rate in December 2025 of +0.9/+3.2/+2.9/+5.0pct. The growth rate in electricity consumption has improved, mainly because the base is relatively low, while economic activity has seen marginal recovery. In January–February 2026, the year-over-year growth rates of electricity consumption for China’s charging-and-swap services industry and for the internet data services industry were 55.1%/46.2%. Growth in electricity demand is being continuously boosted by power substitution and AI development.
Meanwhile, Liaoning Province has clearly set the mechanism for nuclear power unit feed-in tariffs in 2026. According to Liaoning’s Development and Reform Commission, in 2026, Liaoning will establish a price-difference settlement mechanism outside the market for nuclear power. The price-difference settlement fees will temporarily be included in system operation costs and shared by all industrial and commercial users. Under the mechanism tariff is 0.3798 yuan per kWh: about 70% of electricity will be settled under the mechanism tariff, with the rest settled at market electricity prices. Liaoning’s introduction of the nuclear power mechanism feed-in tariff policy provides significant and stable assurance for revenue from nuclear power projects within the province, and is expected to promote nuclear power units to enter the market in a stable manner. It is also expected that other coastal nuclear power provinces will follow suit in sequence. With policy guidance aimed at stabilizing returns on power generation assets, this trend may spread to more regions and types of power sources.
In addition, “computing-power and power collaboration” was written into the government work report for the first time, and green power operations are the core implementation carrier, which is expected to fully benefit. On the news front, on March 23, the National Data Administration stated that the next step will be to work closely with relevant departments to push forward the computing-power and power collaboration project efforts to ensure that the share of green power applications in newly built computing capacity facilities at hub nodes reaches 80% or more, giving full play to green power’s support role to the maximum extent. Green power operations are the core implementation carrier for computing-power and power collaboration. Green power operators are accelerating the transition toward integrated “green power + computing power” operations, upgrading from traditional electricity supply providers to comprehensive computing power service providers. Direct green power supply can both significantly reduce electricity costs for computing-power data centers and meet the policy requirement that green power makes up 80% of the mix. It opens up new earnings growth points for operators and becomes a key realization form for computing-power and power collaboration.
Furthermore, amid geopolitical conflicts, rising oil prices have triggered inflation concerns, while expectations for Federal Reserve rate cuts have been reversed. Risk-hedging sentiment has driven funds toward sectors tied to high dividend payouts. China’s power sector reforms continue to deepen: with the capacity tariff for thermal power units in 2026 rising, the stability of profitability is expected to further improve. At the same time, the improvement in free cash flow of thermal power is prominent, with broad room to increase dividend payout ratios. With hydropower, in a low-interest-rate environment, hydropower dividend yield stocks tend to have relatively high appeal.
Power assets have the characteristics of being heavy-asset, with a low rate of obsolescence. At the same time, emerging development directions such as computing-power and power collaboration + green fuels are expected to further boost overall electricity demand. Interested investors can pay attention to Guotai’s Green Power ETF (159669), focusing on the clean energy power generation field and including operators in thermal power, hydropower, wind power, solar power, and nuclear power.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Today, the pharmaceutical sector also performed well. Guotai’s CSI STAR Innovative Drugs ETF (589720) jumped 4.68%, and Guotai’s Hang Seng Biotech ETF (520930) rose 4.18%.
The 2026 government work report clearly states that biopharmaceuticals will be listed as an “emerging pillar industry.” In introducing the government’s work tasks for this year in the government work report, Premier Li Qiang said that stronger efforts will be made to protect and improve people’s livelihoods, and that strengthening basic public health and medical services is one of the overall requirements. In addition, among the work tasks proposed to accelerate the cultivation and growth of new drivers, biopharmaceuticals are also included as one of the emerging industries and future industries to be developed and expanded.
The clinical R&D progress for innovative drugs continues to advance steadily. Recently, domestically developed innovative drugs have disclosed excellent clinical data at multiple academic conferences. Investors are advised to focus on major academic conferences such as ASCO in the second quarter. Since the first quarter of 2026, the trend of domestically developed innovative drugs going overseas has continued. Through multi-project cooperation agreements achieved based on core technology platforms, it fully demonstrates that China’s innovative drug R&D capability is increasingly being recognized by multinational pharmaceutical companies. Efficiency and cost advantages are becoming even more apparent.
In 2025, performance in the CXO industry showed a differentiated pattern. Most CDMO companies displayed strong profitability growth, while some clinical CRO companies faced demand fluctuations and cost pressure, resulting in performance under pressure. From the perspective of orders, the order performance of the 2025 CXO industry has shown positive signals, indicating that after the rebound in global biopharmaceutical investment and financing activity, CXO industry demand and business conditions have improved.
In addition, amid the AI and big-technology wave, pharmaceuticals are expected to unlock new growth logic. Brain-computer interfaces and AI medical care are also developing rapidly. The pharmaceutical sector’s “chip” position is relatively clean, and potential selling pressure is relatively reduced, providing a higher safety buffer and a favorable allocation window for a possible bottoming-out rebound. With major industry catalysts ahead—such as the ASCO conference—pharmaceutical investors may consider gradually building positions on dips in Guotai’s Hang Seng Biotech ETF (520930) and Guotai’s CSI STAR Innovative Drugs ETF (589720).
Risk disclosure: Investors should fully understand the differences between fund regular investment plans (dollar-cost averaging) and savings methods such as “zero-balance saving” (buying small amounts consistently at fixed intervals). Regular investment plans guide investors toward long-term investing and averaging investment costs through a simple and practical approach. However, regular investment plans cannot eliminate the inherent risks of investing in funds, cannot guarantee that investors will earn returns, and are not an equivalent wealth-management alternative to savings. Whether it is stock ETFs/LOFs/split funds, they are all categories of securities investment funds with relatively higher expected risk and expected return. Their expected returns and expected risk levels are higher than those of hybrid funds, bond funds, and money market funds. If fund assets invest in STAR Market and ChiNext Board stocks, they will face unique risks arising from differences in the underlying investment targets, market systems, and trading rules, among other factors—investors are reminded to pay attention. The short-term gain/loss ranges for sectors/funds are listed only as supplemental materials to the article’s analytical views for reference purposes only and do not constitute any guarantee of fund performance. Short-term performance of individual stocks mentioned in the article is for reference only and does not constitute a stock recommendation, nor does it constitute any prediction or guarantee of fund performance. The above views are for reference only and do not constitute investment advice or commitments. If you need to purchase related fund products, please follow the relevant regulations on investor suitability management, complete risk assessments in advance, and purchase fund products with risk ratings that match your own risk tolerance. Funds involve risk, and investing requires caution.
Special contributor: Guotai Fund
A MACD golden cross signal has formed—these stocks have a good run! ! !
Massive information, precise analysis—right here in the Sina Finance app
责任编辑:杨红卜